Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Progression of excitation-contraction coupling defects in doxorubicin cardiotoxicity.

Llach A, Mazevet M, Mateo P, Villejouvert O, Ridoux A, Rucker-Martin C, Ribeiro M, Fischmeister R, Crozatier B, Benitah JP, Morel E, Gómez AM.

J Mol Cell Cardiol. 2019 Jan;126:129-139. doi: 10.1016/j.yjmcc.2018.11.019. Epub 2018 Nov 28.

PMID:
30500377
2.

Shear Wave Imaging of Passive Diastolic Myocardial Stiffness: Stunned Versus Infarcted Myocardium.

Pernot M, Lee WN, Bel A, Mateo P, Couade M, Tanter M, Crozatier B, Messas E.

JACC Cardiovasc Imaging. 2016 Sep;9(9):1023-1030. doi: 10.1016/j.jcmg.2016.01.022. Epub 2016 May 25.

3.

Response to Schiattarella and Hill.

Crozatier B, Ventura-Clapier R.

Circulation. 2015 Apr 21;131(16):1447. No abstract available.

PMID:
26082962
4.

Inhibition of hypertrophy, per se, may not be a good therapeutic strategy in ventricular pressure overload: other approaches could be more beneficial.

Crozatier B, Ventura-Clapier R.

Circulation. 2015 Apr 21;131(16):1448-57. doi: 10.1161/CIRCULATIONAHA.114.013895. No abstract available.

PMID:
25901070
5.

Carabin protects against cardiac hypertrophy by blocking calcineurin, Ras, and Ca2+/calmodulin-dependent protein kinase II signaling.

Bisserier M, Berthouze-Duquesnes M, Breckler M, Tortosa F, Fazal L, de Régibus A, Laurent AC, Varin A, Lucas A, Branchereau M, Marck P, Schickel JN, Deloménie C, Cazorla O, Soulas-Sprauel P, Crozatier B, Morel E, Heymes C, Lezoualc'h F.

Circulation. 2015 Jan 27;131(4):390-400; discussion 400. doi: 10.1161/CIRCULATIONAHA.114.010686. Epub 2014 Nov 4.

PMID:
25369805
6.

PKC-delta and PKC-epsilon: foes of the same family or strangers?

Duquesnes N, Lezoualc'h F, Crozatier B.

J Mol Cell Cardiol. 2011 Nov;51(5):665-73. doi: 10.1016/j.yjmcc.2011.07.013. Epub 2011 Jul 23. Review.

PMID:
21810427
7.

Real-time assessment of myocardial contractility using shear wave imaging.

Pernot M, Couade M, Mateo P, Crozatier B, Fischmeister R, Tanter M.

J Am Coll Cardiol. 2011 Jun 28;58(1):65-72. doi: 10.1016/j.jacc.2011.02.042.

8.

Rap-linked cAMP signaling Epac proteins: compartmentation, functioning and disease implications.

Breckler M, Berthouze M, Laurent AC, Crozatier B, Morel E, Lezoualc'h F.

Cell Signal. 2011 Aug;23(8):1257-66. doi: 10.1016/j.cellsig.2011.03.007. Epub 2011 Mar 22. Review.

PMID:
21402149
9.

The cardiac renin-angiotensin system is responsible for high-salt diet-induced left ventricular hypertrophy in mice.

Le Corvoisier P, Adamy C, Sambin L, Crozatier B, Berdeaux A, Michel JB, Hittinger L, Su J.

Eur J Heart Fail. 2010 Nov;12(11):1171-8. doi: 10.1093/eurjhf/hfq146. Epub 2010 Sep 24.

10.

Epac stimulation induces rapid increases in connexin43 phosphorylation and function without preconditioning effect.

Duquesnes N, Derangeon M, Métrich M, Lucas A, Mateo P, Li L, Morel E, Lezoualc'h F, Crozatier B.

Pflugers Arch. 2010 Sep;460(4):731-41. doi: 10.1007/s00424-010-0854-9. Epub 2010 Jun 29.

PMID:
20585956
11.

Epac activation induces histone deacetylase nuclear export via a Ras-dependent signalling pathway.

Métrich M, Laurent AC, Breckler M, Duquesnes N, Hmitou I, Courillau D, Blondeau JP, Crozatier B, Lezoualc'h F, Morel E.

Cell Signal. 2010 Oct;22(10):1459-68. doi: 10.1016/j.cellsig.2010.05.014. Epub 2010 May 27.

PMID:
20576488
12.

Role of the cAMP-binding protein Epac in cardiovascular physiology and pathophysiology.

Métrich M, Berthouze M, Morel E, Crozatier B, Gomez AM, Lezoualc'h F.

Pflugers Arch. 2010 Mar;459(4):535-46. doi: 10.1007/s00424-009-0747-y. Epub 2009 Oct 25. Review.

PMID:
19855995
13.

The EGF receptor activates ERK but not JNK Ras-dependently in basal conditions but ERK and JNK activation pathways are predominantly Ras-independent during cardiomyocyte stretch.

Duquesnes N, Vincent F, Morel E, Lezoualc'h F, Crozatier B.

Int J Biochem Cell Biol. 2009 May;41(5):1173-81. doi: 10.1016/j.biocel.2008.09.032. Epub 2008 Oct 28.

PMID:
19015044
14.

Dietary long-chain n-3 fatty acids modify blood and cardiac phospholipids and reduce protein kinase-C-delta and protein kinase-C-epsilon translocation.

Judé S, Martel E, Vincent F, Besson P, Couet C, Ogilvie GK, Pinault M, De Chalendar C, Bougnoux P, Richard S, Champeroux P, Crozatier B, Le Guennec JY.

Br J Nutr. 2007 Dec;98(6):1143-51. Epub 2007 Jul 30.

PMID:
17663802
15.

Central role of PKCs in vascular smooth muscle cell ion channel regulation.

Crozatier B.

J Mol Cell Cardiol. 2006 Dec;41(6):952-5. Epub 2006 Oct 23. Review. No abstract available.

PMID:
17059821
16.

Dual level of interactions between calcineurin and PKC-epsilon in cardiomyocyte stretch.

Vincent F, Duquesnes N, Christov C, Damy T, Samuel JL, Crozatier B.

Cardiovasc Res. 2006 Jul 1;71(1):97-107. Epub 2006 Mar 24.

PMID:
16682016
17.

Impaired alpha1-adrenergic responses in aged rat hearts.

Montagne O, Le Corvoisier P, Guenoun T, Laplace M, Crozatier B.

Fundam Clin Pharmacol. 2005 Jun;19(3):331-9.

PMID:
15910657
18.

Chronic infusion of bradykinin delays the progression of heart failure and preserves vascular endothelium-mediated vasodilation in conscious dogs.

Tonduangu D, Hittinger L, Ghaleh B, Le Corvoisier P, Sambin L, Champagne S, Badoual T, Vincent F, Berdeaux A, Crozatier B, Su JB.

Circulation. 2004 Jan 6;109(1):114-9. Epub 2003 Dec 8.

PMID:
14662711
19.

Effects of nifedipine-induced pulmonary vasodilatation on cardiac receptors and protein kinase C isoforms in the chronically hypoxic rat.

Morel OE, Buvry A, Le Corvoisier P, Tual L, Favret F, León-Velarde F, Crozatier B, Richalet JP.

Pflugers Arch. 2003 Jun;446(3):356-64. Epub 2003 Apr 25.

PMID:
12715180
20.

Different effects of mibefradil and amlodipine on coronary vessels and during beta-adrenergic stimulation in conscious dogs.

Heloire F, Hittinger L, Champagne S, Suto Y, Houel R, Ennezat PV, Sambin L, Crozatier B, Su JB.

J Cardiovasc Pharmacol. 2002 Dec;40(6):898-906.

PMID:
12451323
21.

Thromboxane A2 in vasomotor effects of phenylephrine, acetylcholine, and bradykinin in rat mesenteric bed.

Ben Cheikh R, Féray JC, Alaoui A, Crozatier B.

J Cardiovasc Pharmacol. 2002 Aug;40(2):255-64.

PMID:
12131555
22.

Reduced coronary vasodilator responses to amlodipine in pacing-induced heart failure in conscious dogs: role of nitric oxide.

Champagne S, Hittinger L, Héloire F, Suto Y, Sambin L, Crozatier B, Su JB.

Br J Pharmacol. 2002 May;136(2):264-70.

23.

Role of creatine kinase in cardiac excitation-contraction coupling: studies in creatine kinase-deficient mice.

Crozatier B, Badoual T, Boehm E, Ennezat PV, Guenoun T, Su J, Veksler V, Hittinger L, Ventura-Clapier R.

FASEB J. 2002 May;16(7):653-60.

PMID:
11978729
24.

Interaction of chelerythrine with inositol phosphate metabolism.

Le Corvoisier P, Lacotte J, Laplace M, Crozatier B.

Fundam Clin Pharmacol. 2002 Feb;16(1):31-7.

PMID:
11903510
25.

Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice.

Meneton P, Bloch-Faure M, Hagege AA, Ruetten H, Huang W, Bergaya S, Ceiler D, Gehring D, Martins I, Salmon G, Boulanger CM, Nussberger J, Crozatier B, Gasc JM, Heudes D, Bruneval P, Doetschman T, Ménard J, Alhenc-Gelas F.

Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2634-9. Epub 2001 Feb 20.

26.

Differential alterations in cardiac adrenergic signaling in chronic hypoxia or norepinephrine infusion.

León-Velarde F, Bourin MC, Germack R, Mohammadi K, Crozatier B, Richalet JP.

Am J Physiol Regul Integr Comp Physiol. 2001 Jan;280(1):R274-81.

27.

Loss of the normal epicardial to endocardial gradient of cftr mRNA expression in the hypertrophied rabbit left ventricle.

Wong KR, Trezise AE, Crozatier B, Vandenberg JI.

Biochem Biophys Res Commun. 2000 Nov 11;278(1):144-9.

PMID:
11071866
28.

Altered balance between matrix gelatinases (MMP-2 and MMP-9) and their tissue inhibitors in human dilated cardiomyopathy: potential role of MMP-9 in myosin-heavy chain degradation.

Rouet-Benzineb P, Buhler JM, Dreyfus P, Delcourt A, Dorent R, Perennec J, Crozatier B, Harf A, Lafuma C.

Eur J Heart Fail. 1999 Dec;1(4):337-52.

29.

Stimulation of bradykinin B(1) receptors induces vasodilation in conductance and resistance coronary vessels in conscious dogs: comparison with B(2) receptor stimulation.

Su JB, Hoüel R, Héloire F, Barbe F, Beverelli F, Sambin L, Castaigne A, Berdeaux A, Crozatier B, Hittinger L.

Circulation. 2000 Apr 18;101(15):1848-53.

PMID:
10769287
30.

Propofol-induced modifications of cardiomyocyte calcium transient and sarcoplasmic reticulum function in rats.

Guenoun T, Montagne O, Laplace M, Crozatier B.

Anesthesiology. 2000 Feb;92(2):542-9.

PMID:
10691243
31.

Increased bradykinin levels accompany the hemodynamic response to acute inhibition of angiotensin-converting enzyme in dogs with heart failure.

Su JB, Barbe F, Crozatier B, Campbell DJ, Hittinger L.

J Cardiovasc Pharmacol. 1999 Nov;34(5):700-10.

PMID:
10547087
32.

Induction of cardiac nitric oxide synthase 2 in rats exposed to chronic hypoxia.

Rouet-Benzineb P, Eddahibi S, Raffestin B, Laplace M, Depond S, Adnot S, Crozatier B.

J Mol Cell Cardiol. 1999 Sep;31(9):1697-708.

PMID:
10471353
33.
34.

Cytosolic myocardial calcium modulation by ATP-dependent potassium channel openers and NO donors.

Laplace M, Guenoun T, Montagne O, Roser F, Crozatier B.

J Cardiovasc Pharmacol. 1999 Mar;33(3):394-400.

PMID:
10069674
35.

[Physiopathological basis of the treatment of heart failure].

Vinsonneau C, Su JB, Benacerraf S, Darmon ME, Duval-Moulin AM, Crozatier B, Dubois-Randé JL, Castaigne A, Hittinger L.

Arch Mal Coeur Vaiss. 1998 Nov;91(11):1315-24. French.

PMID:
9864599
36.

Acute effects of an endothelin-1 receptor antagonist bosentan at different stages of heart failure in conscious dogs.

Choussat R, Hittinger L, Barbe F, Maistre G, Carayon A, Crozatier B, Su J.

Cardiovasc Res. 1998 Sep;39(3):580-8.

PMID:
9861300
37.

Preserved vasodilator effect of bradykinin in dogs with heart failure.

Su JB, Barbe F, Houel R, Guyene TT, Crozatier B, Hittinger L.

Circulation. 1998 Dec 22-29;98(25):2911-8.

PMID:
9860795
38.

Force-frequency relations in nonfailing and failing animal myocardium.

Crozatier B.

Basic Res Cardiol. 1998;93 Suppl 1:46-50. Review.

PMID:
9833130
39.

Protein kinase C activity and expression in rabbit left ventricular hypertrophy.

Mohammadi K, Rouet-Benzineb P, Laplace M, Crozatier B.

J Mol Cell Cardiol. 1997 Jun;29(6):1687-94.

PMID:
9220354
40.

Regional myocardial effects of intracoronary bradykinin in conscious dogs.

Houel R, Su J, Barbe F, Choussat R, Crozatier B, Hittinger L.

Am J Physiol. 1997 Mar;272(3 Pt 2):H1266-74.

PMID:
9087601
41.

Endogenous sodium-potassium-chloride cotransport inhibitor in congestive heart failure.

Dubois-Randé JL, Montagne O, Alvarez-Guerra M, Nazaret C, Crozatier B, Gueret P, Castaigne A, Garay RP.

J Am Coll Cardiol. 1996 Nov 15;28(6):1464-70.

42.

Protein kinase C isoform expression in normal and failing rabbit hearts.

Rouet-Benzineb P, Mohammadi K, Pérennec J, Poyard M, Bouanani Nel-H, Crozatier B.

Circ Res. 1996 Aug;79(2):153-61.

PMID:
8755991
43.
44.

Bradykinin pathway is involved in acute hemodynamic effects of enalaprilat in dogs with heart failure.

Barbe F, Su JB, Guyene TT, Crozatier B, Ménard J, Hittinger L.

Am J Physiol. 1996 Jun;270(6 Pt 2):H1985-92.

PMID:
8764248
45.

Regional alterations of left ventricular contraction and inotropic reserve in conscious dogs with heart failure.

Su JB, Barbe F, Laplace M, Crozatier B, Hittinger L.

Cardiovasc Res. 1995 Dec;30(6):848-56.

PMID:
8746198
46.

Differential regulation of G protein expression in rat hearts exposed to chronic hypoxia.

Kacimi R, Moalic JM, Aldashev A, Vatner DE, Richalet JP, Crozatier B.

Am J Physiol. 1995 Dec;269(6 Pt 2):H1865-73.

PMID:
8594894
47.

Inotropic effects of ouabain and Na, K-ATPase activity in failing rabbit hearts.

Ezzaher A, Mougenot R, Baggioni A, el Ouazzani T, Crozatier B, Maixent JM.

C R Acad Sci III. 1995 Feb;318(2):273-9.

PMID:
7757817
48.
49.

Timing and velocity of ejection as major determinants of end-systolic pressure in isolated rabbit hearts.

Ezzaher A, el Ouazzani T, Crozatier B.

Circulation. 1994 Dec;90(6):3055-62.

PMID:
7994854

Supplemental Content

Loading ...
Support Center